Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Submitted by
admin
on October 17, 2011 - 9:27am
Source:
Yahoo/AP
News Tags:
Roche
M&A
Anadys
hepatitis C
Headline:
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Do Not Allow Advertisers to Use My Personal information
